Janus kinase (JNK) inhibitors with antiviral and anti-inflammatory properties have shown promising results in the treatment of symptomatic patients with coronavirus 2019 (COVID-19). In a systematic review article published in …
Scientists are evaluating JNK inhibitors in the treatment of moderate to severe COVID-19 patients Read MoreThe ongoing development of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), has prolonged the current epidemic. This has given rise to several …
Appreciation for the fitness advantage of Omicron Read MoreIn a recent study published in medRxiv*Preprint server Researchers have investigated the effectiveness of nirmatrelvir plus ritonavir in preventing hospitalization in individuals 50 years of age or older who have …
Real-world study shows Paxlovid linked to lower hospitalization rates Read MoreIn a recent study published in bioRxiv* Prepress server, Weill Cornell Medical College researchers assessed the cleavability of spike (S) protein cleavage of SARS-CoV-2 variants of concern (VOCs) and related …
SARS-CoV-2 variants of concern display contrasting interactions with host proteases Read MoreIn a recent article published on medRxiv* Preprint server Scientists have evaluated the effectiveness of initial and booster regimens of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccinations in preventing …
Study confirms increased protection from Omicron-related hospitalization by COVID enhancers Read MoreIn a recent study published in bioRxiv* Prepress server, researchers show that coronavirus disease 2019 (COVID-19) convalescent plasmas (CCPs) with low neutralizing and crystallable (Fc) active activity lead to effective …
FC responder functions for COVID-19 convalescent plasma selection Read MoreA recent systematic review has been published on medRxiv* The prepress server investigated the effectiveness of non-pharmacological interventions for post-viral syndromes (PVS), including post-coronavirus disease 2019 (COVID-19). The study: Non-pharmacological …
Efficacy of non-pharmacological treatments for post-viral syndromes and prolonged COVID Read MoreThe last 1/2 stage study is under review in nature wallet magazine and published in search field*Preprint server showed that the peptide-focused CoVac-1 T-cell activator and SARS-CoV-2 was effective in …
Trial of a SARS-CoV-2 peptide-based T-cell activator in B-cell-deficient individuals Read MoreIn a recent study published in cellIn this study, researchers evaluated host immune responses to four vaccines for coronavirus disease 2019 (COVID-19) representing three different vaccine technology platforms, with a …
Direct comparison of immune memory responses to four COVID-19 vaccines Read MoreIn a recent article published on medRxiv* Preprint server Researchers show the short-term protection conferred by the coronavirus 2 (SARS-CoV-2) BNT162b2 vaccine in adolescents and children. Study: Primary protection against …
Short-term immunity provided by the COVID-19 BNT162b2 vaccine in adolescents and children Read More